Coherus Oncology, Inc. (CHRS)
NASDAQ: CHRS · Real-Time Price · USD
1.230
+0.100 (8.85%)
At close: Aug 22, 2025, 4:00 PM
1.190
-0.040 (-3.25%)
After-hours: Aug 22, 2025, 6:18 PM EDT

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202013 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2013 - 2019
Human Pharmaceutical Products
266.96M
Log In
Log In
Log In
Log In
Upgrade
Human Pharmaceutical Products Growth
3.78%
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202013 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2013 - 2019
United States
266.96M
Log In
Log In
Log In
Log In
Upgrade
United States Growth
3.78%
Log In
Log In
Log In
Log In
Upgrade